AOL Money & Finance

Health care questions (rip-off) abound -- ABT, JNJ, NVS & TEVA

More

One of the complaints we often hear is that the private insurance companies are gouging customers, second guessing doctors, and cutting corners at every turn to increase profit margins. A great deal of this is true and I would not debate that this dilutes the quality of health care in the United States.

Is the corollary that the government intends to run a health care program that does not make a profit?

That is a very probable outcome. If that is the case then how is it possible that the government will be able to fund something that is a money loser from the get go?

If the government intends to make a profit but just limit it to some margin, what will that margin be and shouldn't it be prescribed in the new legislation?

Another question I have is how we can reduce health care cost nationally from what is double that of any other western nation by starting off with a new program that could add a trillion dollars to the deficit? To me that is a trillion dollars more than we are spending now. How does that save anything at all? In some way, are we not gouging the taxpayer once again in a big way?

When Obama was running for president he often mentioned that the United States had 45 million people that were uninsured or under-insured. That is about 15% of the nation. How many of those people are under 30 years old and choose not to pay for insurance? How many of those people are between jobs and will be insured when they find new employment? How many of those people are receiving free care at hospitals and clinics through donations and local government support? Perhaps the real number of people going without is half that, or 7.5% of the population.

As any business person, statistician, engineer, or scientist will tell you, paying for that last few percent is the most expensive portion to cover. The other issue is that we might be able to cover the cost by examining where current funding is going and do that more efficiently rather than start huge new government programs.

Two final thoughts for discussion. First, who, if anyone, is volunteering to reduce their coverage to pay for someone elses? Second, would there be anything wrong with our nation finding the money for a new program before it spent money that we do not have, mortgaging our children's future even further?

As the debate continues, the stock market is down today so investors should have their watch-list at the ready. The following four stocks, that I have covered before, should do well no matter where the health care debate leads.

All of these companies are known for their strong management, broad product lines, and they all pay dividends. As an added bonus these companies give you exposure to international growth as JNJ and ABT do half their business outside the US as does NVS headquartered in Switzerland and Teva headquartered in Israel. Another bonus, Teva and Novartis are the No.1 and 2 generic drug manufacturers in the world.

These stocks are at the low end of their trading range and rather than speculate how low you might be able to buy them, I would recommend dollar cost averaging to establish a long term problem.

Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture and planning firm. He writes the columns Chasing Value and Serious Money. Disclosure: I own shares of JNJ.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 25, 2009: 07:32 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines